Advanced search
1 file | 386.44 KB

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

(2010) OSTEOPOROSIS INTERNATIONAL. 21(10). p.1657-1680
Author
Organization
Abstract
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.
Keywords
RANDOMIZED CONTROLLED-TRIAL, VITAMIN-D SUPPLEMENTATION, MONTHLY ORAL IBANDRONATE, VERTEBRAL FRACTURE RISK, CONTINUING OUTCOMES RELEVANT, HORMONE REPLACEMENT THERAPY, INTRAVENOUS ZOLEDRONIC ACID, CONTROLLED CLINICAL-TRIAL, PLACEBO-CONTROLLED TRIAL, LONG-TERM EXTENSION, Bisphosphonate, Osteoporosis, Raloxifene, Strontium, Teriparatide

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 386.44 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Body, JJ, P Bergmann, S Boonen, Y Boutsen, JP Devogelaer, Stefan Goemaere, Jean Kaufman, S Rozenberg, and JY Reginster. 2010. “Evidence-based Guidelines for the Pharmacological Treatment of Postmenopausal Osteoporosis: a Consensus Document by the Belgian Bone Club.” Osteoporosis International 21 (10): 1657–1680.
APA
Body, J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J., Goemaere, S., Kaufman, J., et al. (2010). Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. OSTEOPOROSIS INTERNATIONAL, 21(10), 1657–1680.
Vancouver
1.
Body J, Bergmann P, Boonen S, Boutsen Y, Devogelaer J, Goemaere S, et al. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. OSTEOPOROSIS INTERNATIONAL. 2010;21(10):1657–80.
MLA
Body, JJ, P Bergmann, S Boonen, et al. “Evidence-based Guidelines for the Pharmacological Treatment of Postmenopausal Osteoporosis: a Consensus Document by the Belgian Bone Club.” OSTEOPOROSIS INTERNATIONAL 21.10 (2010): 1657–1680. Print.
@article{1194299,
  abstract     = {Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.},
  author       = {Body, JJ and Bergmann, P and Boonen, S and Boutsen, Y and Devogelaer, JP and Goemaere, Stefan and Kaufman, Jean and Rozenberg, S and Reginster, JY},
  issn         = {0937-941X},
  journal      = {OSTEOPOROSIS INTERNATIONAL},
  keyword      = {RANDOMIZED CONTROLLED-TRIAL,VITAMIN-D SUPPLEMENTATION,MONTHLY ORAL IBANDRONATE,VERTEBRAL FRACTURE RISK,CONTINUING OUTCOMES RELEVANT,HORMONE REPLACEMENT THERAPY,INTRAVENOUS ZOLEDRONIC ACID,CONTROLLED CLINICAL-TRIAL,PLACEBO-CONTROLLED TRIAL,LONG-TERM EXTENSION,Bisphosphonate,Osteoporosis,Raloxifene,Strontium,Teriparatide},
  language     = {eng},
  number       = {10},
  pages        = {1657--1680},
  title        = {Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club},
  url          = {http://dx.doi.org/10.1007/s00198-010-1223-4},
  volume       = {21},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: